Glycoconjugate synthesis

US9816122B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9816122-B2
Application numberUS-201314430930-A
CountryUS
Kind codeB2
Filing dateSep 25, 2013
Priority dateSep 25, 2012
Publication dateNov 14, 2017
Grant dateNov 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a method for producing a glycoconjugate comprising an oligosaccharide part covalently linked to a non-sugar moiety selected from the group consisting of amino acids, peptides, proteins, lipids, longer alkyl groups, polyethylene glycols, α,β-unsaturated amido group and polyvinyl alcohols, using a genetically modified cell.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing a glycoconjugate comprising an oligosaccharide part covalently linked to a polyethylene glycol, the method comprising: (i) providing a genetically modified cell comprising a gene encoding a glycosyl transferase enzyme that is able to transfer the glycosyl residue of an activated sugar nucleotide to an internalized acceptor and a gene encoding the E. coli lactose permease, (ii) culturing said genetically modified cell in the presence of an exogenous acceptor according to formula 7 wherein n is an integer from 2 to 6, inducing (a) internalization of the exogenous acceptor by the genetically modified cell, and (b) formation of said glycoconjugate from said internalized acceptor molecule by a glycosyl transfer mediated by said glycosyl transferase enzyme expressed by said cell, and then (iii) collecting said glycoconjugate from the fermentation broth. 2. The method according claim 1 , wherein said genetically modified cell provided in step (i) further comprises a set of genes encoding enzymes responsible for the synthesis of said activated sugar nucleotide by a de novo pathway, and wherein said culturing step (ii) further induces producing said activated sugar nucleotide by a de novo pathway. 3. The method according to claim 1 , wherein said glycosyl transferase enzyme is selected from the group consisting of N-acetyl-glucosaminyl transferases, galactosyl transferases, N-acetyl-galactosaminyl transferases, glucuronosyl transferases, sialyl transferases and fucosyl transferases. 4. The method according to claim 3 , wherein said glycosyl transferase enzyme is α-1,2-fucosyl transferase. 5. The method according to claim 3 , wherein said glycosyl transferase enzyme is selected from the group consisting of β-1,3-N-acetyl-glucosaminyl transferase, β-1,6-N-acetyl-glucosaminyl transferase, β-1,3-galactosyl transferase, β-1,4-galactosyl transferase, α-2,3-sialyl transferase, α-2,6-sialyl transferase, α-1,2-fucosyl transferase, α-1,3-fucosyl transferase and α-1,4-fucosyl transferase. 6. The method according to claim 1 , wherein the genetically modified cell is a bacterium or yeast. 7. The method according to claim 1 , wherein the genetically modified cell is E. coli of LacZ − , LacY + genotype, the exogenous acceptor is a lactose covalently linked to a polyethylene glycol, the glycosyl transferase is a fucosyl transferase, and/or a sialyl transferase, and/or an N-acetylglucosaminyl transferase and/or a galactosyl transferase, and the glycoconjugate produced by the method is a fucosylated and/or sialylated and/or N-acetylglucosaminylated and/or galactosylated lactose covalently linked to a polyethylene glycol. 8. The method according to claim 7 , wherein the exogenous acceptor consists of lactose covalently linked to said polyethylene glycol and the glycoconjugate is a fucosylated lactose covalently linked to polyethylene glycol. 9. The method according to claim 7 , wherein the oligosaccharide part of the glycoconjugate is a human milk oligosaccharide. 10. The method according to claim 9 , wherein the human milk oligosaccharide is selected from the group consisting of 2′-fucosyllactose, 3-fucosyllactose, difucosyllactose, 3′-sialyllactose, 6′-sialyllactose, 3′-sialyl-3-fucosyllactose, lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT). 11. The method according to claim 8 , wherein the glycoconjugate is a compound of formula 7a wherein Y is a human milk oligosaccharide glycosyl residue, and n is an integer from 2-6. 12. The method according to claim 11 , wherein n is an integer of from 2 to 4. 13. The method according to claim 11 , wherein the compound of formula 7a is of formula 8d wherein R 1 is fucosyl or H, R 2 is fucosyl or H, n is an integer from 2 to 6, provided that at least one of the R 1 and R 2 groups is fucosyl. 14. The method according to claim 13 , wherein n is an integer of from 2 to 4.

Assignees

Inventors

Classifications

  • Acyclic or carbocyclic radicals, substituted by hetero rings · CPC title

  • C12P19/44Primary

    Preparation of O-glycosides, e.g. glucosides {(polysaccharides and not substituted disaccharides C12P19/04, C12P19/12)} · CPC title

  • attached to an oxygen atom of the saccharide radical · CPC title

  • having the esterifying carboxyl radicals attached to acyclic carbon atoms · CPC title

  • Polyoxyalkylene derivatives · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9816122B2 cover?
The invention relates to a method for producing a glycoconjugate comprising an oligosaccharide part covalently linked to a non-sugar moiety selected from the group consisting of amino acids, peptides, proteins, lipids, longer alkyl groups, polyethylene glycols, α,β-unsaturated amido group and polyvinyl alcohols, using a genetically modified cell.
Who is the assignee on this patent?
Glycom As
What technology area does this patent fall under?
Primary CPC classification C12P19/44. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).